EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Significance of Time‐to‐Surgery and COVID ‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer

Áron Ghimessy iD, János Fillinger, Márton Csaba, Sára Lality, Gábor Tarsoly, Hanna Tihanyi, Kristóf Csende, Péter Radeczky, Balázs Gieszer, Levente Bogyó, Klára Török, László Mészáros und 7 weitere

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Áron Ghimessy und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, COVID-19, Lung Neoplasms, Time-to-Treatment. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Hungarian National Research, Development and Innovation Office, New National Excellence Program of the Ministry for Innovation and Technology of Hungary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Timely discovery and adequate patient management are crucial in non‐small cell lung cancer (NSCLC) since long‐term survival is only achievable in early‐stage disease. In our study, we aimed to elucidate the effects of time to surgery on survival and to assess the impact of the COVID‐19 pandemic on elapsed time until surgery.

Methods

In total, 2536 Caucasian NSCLC patients who underwent curative‐intent lung resection surgery were included in this study. 1 month, 2 months, 77 days, and 91.06 days between CT‐based diagnosis and surgery were evaluated as possible cut‐off values for worse outcome. Survival curves were estimated by Kaplan–Meier plots, and the differences between groups were compared using the log‐rank test. Multivariate analysis was performed using a Cox regression model.

Results

Patients with time‐to‐surgery ≥ 2 months had significantly impaired overall survival (OS) (vs. those with < 2 months; p = 0.002). In our multivariate model, time‐to‐surgery ( p = 0.011), age ( p = 0.02), diabetes mellitus ( p = 0.02), disease stage ( p = 0.0001) and vascular invasion ( p < 0.001) all had a significant impact on OS. Importantly, during the COVID‐19 pandemic, the elapsed time between diagnosis and surgery increased with a median of 12 days, resulting in a significant delay in time‐to‐surgery compared to the pre‐pandemic period ( p < 0.001). Post hoc tests showed, however, that there were no significant differences in time‐to‐surgery concerning the major waves of COVID‐19 infections.

Conclusions

Time‐to‐surgery is an independent predictor of long‐term survival in surgically treated NSCLC. In general, the COVID‐19 pandemic caused a significant delay in the elapsed time until surgery, but the specific COVID‐19 waves had no significant impact on time‐to‐surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCOVID-19Lung NeoplasmsTime-to-TreatmentHumansMaleFemaleAgedMiddle AgedSARS-CoV-2Aged, 80 and overPandemicsRetrospective StudiesClinical Relevance

Stichwörter der Autor:innen

COVID‐19 pandemicNSCLCtime‐to‐surgery

Autor:innen und Institutionen

  • Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.
  • Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary.
  • National Korányi Institute of Pulmonology, Budapest, Hungary.
  • Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Department of Translational Medicine, Lund University, Lund, Sweden.
  • National Institute of Oncology and National Tumor Biology Laboratory, Budapest, Hungary.

ORCID-Profile: Áron Ghimessy, Balázs Döme

Förderung

  • Austrian Science Fund
  • Hungarian National Research, Development and Innovation Office
  • New National Excellence Program of the Ministry for Innovation and Technology of Hungary
  • Bolyai Research Scholarship of the Hungarian Academy of Sciences
  • Semmelweis University
  • Semmelweis Egyetem

Zitieren

APA

Ghimessy, Á., Fillinger, J., Csaba, M., Lality, S., Tarsoly, G., Tihanyi, H., Csende, K., Radeczky, P., Gieszer, B., Bogyó, L., Török, K., Mészáros, L., Gellért, Á., Ferencz, B., Döme, B., Kocsis, Á., Agócs, L., Rényi-Vámos, F., & Megyesfalvi, Z. (2025). Clinical Significance of Time‐to‐Surgery and COVID ‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70163

Vancouver

Ghimessy Á, Fillinger J, Csaba M, Lality S, Tarsoly G, Tihanyi H, et al. Clinical Significance of Time‐to‐Surgery and COVID ‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70163

BibTeX
@article{Ghimessy2025,
  author = {Ghimessy, Áron and Fillinger, János and Csaba, Márton and Lality, Sára and Tarsoly, Gábor and Tihanyi, Hanna and Csende, Kristóf and Radeczky, Péter and Gieszer, Balázs and Bogyó, Levente and Török, Klára and Mészáros, László and Gellért, Áron and Ferencz, Bence and Döme, Balázs and Kocsis, Ákos and Agócs, László and Rényi-Vámos, Ferenc and Megyesfalvi, Zsolt},
  title = {Clinical Significance of Time‐to‐Surgery and COVID ‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70163}
}
Kostenlos starten →